Trial intelligence / Profile preview

Chlorhexidine vs plant-based mouthwash to prevent ventilator-associated pneumonia

IRCT20200413047059N1Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of chlorhexidine in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Incidence of ventilator-associated pneumonia. Started Jul 2018; status: completed.

02

Drugs

chlorhexidine
03

Conditions

ventilator-associated pneumonia (VAP)

Beyond the preview

Go deeper on IRCT20200413047059N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200413047059N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call